CDIB Capital has confirmed completion of its NT$1.9 billion ($61 million) acquisition of Taiwanese chemicals producer Jintex.
The investor has acquired an 81.2% stake in the Taipei-listed company at NT$27.50 per share. This offer was first submitted in March, when shares were trading around NT$25.00 apiece. The stock has traded...
KKR has offered to acquire up to 9% of First Gen Corporation, a power plant operator in the Philippines, for PHP7.29 billion ($144 million).
Japan’s Beyond Next Ventures has led a JPY800 billion ($7.4 million) Series A round for local cell-based agricultural technology specialist IntegriCulture.
Chinese drug developer Jiangsu Atom Bioscience & Pharmaceutical has raised $30 million in Series B funding led by Sequoia Capital China and Hong Kong-listed Livzon Pharmaceutical Group.
Hillhouse Capital has led an extended Series A round of funding worth $50 million for Deepexi, a Chinese start-up that provides a suite of smart data services to enterprise customers.